Pediatric Gastroenterology

Vaccination Rates for High-Risk Populations

Published pediatric treatment guidelines recommend that all children > 6 months of age receive an annual influenza vaccination.1 Children and adolescents with inflammatory bowel disease (IBD) on either immunomodulators or biologic therapies and children being treated with combination immunosuppressive medication regimens following liver and intestinal transplantation can be immune compromised, which increases their risk for significant infection. The Department of Pediatric Gastroenterology’s goal is to discuss the importance of annual influenza vaccination with all patients and their families, as well as to offer annual vaccination. Vaccine administration compliance in patients with IBD receiving regular infliximab infusions, and in patients following liver and intestinal transplant, were documented.

Influenza Immunization Compliance in Pediatric Patients (N = 231)

2018 - 2019 Flu Season

IBD = inflammatory bowel disease

¹All patients were contacted to receive the vaccine. Some patients did not respond, which accounts for the additional 26% of patients who were offered the vaccine, but did not receive the vaccine through our office.

In 2018, the department reviewed the importance of annual influenza vaccine with 100% of patients. The overall influenza immunization compliance rate in these at-risk patients was 81.8%. The department’s immunization rate is above the National Immunization Survey-Flu vaccination rate (2017–2018) of 45.6% for patients aged 6 months to 17 years. ¹